| Bioactivity | Tyroserleutide (YSL), isolated from the degradation products of porcine spleen[1], is a small molecular tripeptide which inhibits tumor growth both in vitro and in vivo[2]. |
| Invitro | Tyroserleutide (YSL) exhibits immuno-modulating effects, such as enhancing concanavalin (ConA) induced proliferation of mouse spleen lymphocytes, phagocytosis of mouse peritoneal macrophages, and the activity of natural killer (NK) cells[1].Tyroserleutide (YSL), an immunologically therapeutic tripeptide, can promote hepatocarcinoma cell (H22) apoptosis through downregulating Bcl-2 and cyclin D1 expression[2]. Tyroserleutide is an ideal choice for inducing apoptosis of liver tumor cells[2]. Tyroserleutide inhibits tumor growth and does not cause severe toxicities in the major organs. Tyroserleutide can inhibit tumor cell migration[2]. |
| Name | Tyroserleutide |
| CAS | 138168-48-6 |
| Formula | C18H27N3O6 |
| Molar Mass | 381.42 |
| Transport | Room temperature in continental US; may vary elsewhere. |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
Tyroserleutide
CAS: 138168-48-6 F: C18H27N3O6 W: 381.42
Tyroserleutide (YSL), isolated from the degradation products of porcine spleen, is a small molecular tripeptide which in
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.